We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Pharma Exclusivity Could Be Sticking Point in Pacific Rim Trade Talks
Pharma Exclusivity Could Be Sticking Point in Pacific Rim Trade Talks
Pharmaceutical intellectual property rights remain a significant sticking point in a proposed draft of the massive Trans-Pacific Partnership (TPP) trade pact leaked last month.